18/07/2026
Precious moments with Dr Rispah Torrorey from Eldoret Kenya, exchanging ideas on how to increase access to breast cancer genomics in underserved African regions.
Gknowmix develops tests that help clinicians to prevent or treat chronic diseases with a genetic com
Sevice delivery is driven by cutting-edge research performed in the pathology Research Facility of the University of Stellenbosch.
18/07/2026
Precious moments with Dr Rispah Torrorey from Eldoret Kenya, exchanging ideas on how to increase access to breast cancer genomics in underserved African regions.
21/06/2026
Implementing a novel genetic counselling model using the CarePoint BRCA Assay - where precision oncology begins!
Two of the cancer patients participating in this pilot access program led by Prof Maritha Kotze and Dr Chantelle Jennifer Scott proceeded with whole genome sequencing (WGS) - an extension of the Wellness GeneScreen focused on risk and treatment stratification into inherited, lifestyle-triggered and therapy-associated pathologies. The value of the BRCA point-of-care assay was first demonstrated by Lwando Mampunye in early-stage breast cancer patients referred for the assay. It is also used in combination with the NGS Assay as presented by Dr Rika Pienaar at the User Group meeting in Spain during April 2026.
Janine Forbes - Cronje you and your company Carepoint Genetics made a huge contribution to the success of multidisciplinary research translation. Thank you!
Celebrating my 14th year on Facebook. Thank you for your continuing support. We could never have made it without you. 🙏🤗🎉